BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17214441)

  • 21. Signaling complex organization by PDZ domain proteins.
    Fan JS; Zhang M
    Neurosignals; 2002; 11(6):315-21. PubMed ID: 12566920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and function of PICK1.
    Xu J; Xia J
    Neurosignals; 2006-2007; 15(4):190-201. PubMed ID: 17215589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frizzled 7 and PIP2 binding by syntenin PDZ2 domain supports Frizzled 7 trafficking and signalling.
    Egea-Jimenez AL; Gallardo R; Garcia-Pino A; Ivarsson Y; Wawrzyniak AM; Kashyap R; Loris R; Schymkowitz J; Rousseau F; Zimmermann P
    Nat Commun; 2016 Jul; 7():12101. PubMed ID: 27386966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PDZ-containing proteins: alternative splicing as a source of functional diversity.
    Sierralta J; Mendoza C
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):105-15. PubMed ID: 15572166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing phosphoinositide functions in signaling and membrane trafficking.
    Downes CP; Gray A; Lucocq JM
    Trends Cell Biol; 2005 May; 15(5):259-68. PubMed ID: 15866030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organization of signaling complexes by PDZ-domain scaffold proteins.
    Zhang M; Wang W
    Acc Chem Res; 2003 Jul; 36(7):530-8. PubMed ID: 12859214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing the supramodular architecture of a multidomain protein: the structure of syntenin in solution.
    Cierpicki T; Bushweller JH; Derewenda ZS
    Structure; 2005 Feb; 13(2):319-27. PubMed ID: 15698575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Syntenin: PDZ Protein Regulating Signaling Pathways and Cellular Functions.
    Shimada T; Yasuda S; Sugiura H; Yamagata K
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of drug transporters by PDZ adaptor proteins and nuclear receptors.
    Kato Y; Watanabe C; Tsuji A
    Eur J Pharm Sci; 2006 Apr; 27(5):487-500. PubMed ID: 16376527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Great expectations for PIP: phosphoinositides as regulators of signaling during development and disease.
    Skwarek LC; Boulianne GL
    Dev Cell; 2009 Jan; 16(1):12-20. PubMed ID: 19154715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adaptor proteins of blood platelets].
    Kralisz U
    Postepy Biochem; 2005; 51(3):308-17. PubMed ID: 16381175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of phosphoinositide binding to K(+) channel subunits using a protein-lipid overlay assay.
    Thomas AM; Tinker A
    Methods Mol Biol; 2008; 491():103-11. PubMed ID: 18998087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphoinositides: regulators of membrane traffic and protein function.
    Krauss M; Haucke V
    FEBS Lett; 2007 May; 581(11):2105-11. PubMed ID: 17316616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoinhibition of X11/Mint scaffold proteins revealed by the closed conformation of the PDZ tandem.
    Long JF; Feng W; Wang R; Chan LN; Ip FC; Xia J; Ip NY; Zhang M
    Nat Struct Mol Biol; 2005 Aug; 12(8):722-8. PubMed ID: 16007100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, specificity and determinants of lipid-interacting PDZ domains from an in-cell screen and in vitro binding experiments.
    Ivarsson Y; Wawrzyniak AM; Kashyap R; Polanowska J; Betzi S; Lembo F; Vermeiren E; Chiheb D; Lenfant N; Morelli X; Borg JP; Reboul J; Zimmermann P
    PLoS One; 2013; 8(2):e54581. PubMed ID: 23390500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenesis and selection of PDZ domains that bind new protein targets.
    Schneider S; Buchert M; Georgiev O; Catimel B; Halford M; Stacker SA; Baechi T; Moelling K; Hovens CM
    Nat Biotechnol; 1999 Feb; 17(2):170-5. PubMed ID: 10052354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bivalent peptides as models for multimeric targets of PDZ domains.
    Paduch M; Biernat M; Stefanowicz P; Derewenda ZS; Szewczuk Z; Otlewski J
    Chembiochem; 2007 Mar; 8(4):443-52. PubMed ID: 17279591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A flexible docking procedure for the exploration of peptide binding selectivity to known structures and homology models of PDZ domains.
    Niv MY; Weinstein H
    J Am Chem Soc; 2005 Oct; 127(40):14072-9. PubMed ID: 16201829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphoinositides and PDZ domain scaffolds.
    Wawrzyniak AM; Kashyap R; Zimmermann P
    Adv Exp Med Biol; 2013; 991():41-57. PubMed ID: 23775690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The C2 domains of classical PKCs are specific PtdIns(4,5)P2-sensing domains with different affinities for membrane binding.
    Guerrero-Valero M; Marín-Vicente C; Gómez-Fernández JC; Corbalán-García S
    J Mol Biol; 2007 Aug; 371(3):608-21. PubMed ID: 17586528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.